Replies to post #178375 on Kraig Biocraft Laboratories Inc (KBLB)

[jose0505]

I doubt very seriously that thanksgiving is the deadline, the process is almost complete you don’t scrap all the work you have done to this point and start over in spring, as to when though I don’t know exact dates, but I know from my professional life that kraig is having the discussions necessary to uplist, the wild card here is the financing, I do not believe it will be a solution based financing like calm seas in the past.

The funny thing is how some want to say uplisting doesn’t change the company I disagree, but let’s say they are right uplisting doesn’t change the way this company looks... why would they do it? I hear some say uplisting won’t bring any better terms then why do it?

DILUTION keeps being used as a scare tactic, we are r/s just to dilute, lol if that was the case he could have just done that already what’s stopping him from doing it now? Lol then they say oh he will lose control of the company, yet try pint out he has all the power so why not just issue more super voting shares

At the end of the day too many straw man arguments so I don’t bother wasting my time

The uplist is extra work if he is doing it there is a good reason why... he wouldn’t be “milking” this like some say and be doing all this work to get uplisted just for fun if he could just keep keep selling shares to fill his pockets like some love to say

[Dibuzu]

Feels like the investors are being handled. I read nothing but blue sky shill-man-ship.
-Production
-Quality, and lab results to back up those quality statements.
- Gaining finance
- Hiring a business developer ( sales)
-Stop hoping that up listing will fix everything; financing, material becomes attractive to industry, sales, and proven production.
None of these question are/ were handled with specifics enough to give me hope that KBLB is being guided into industry properly and in substantive manner!